COMMUNIQUÉS West-GlobeNewswire

MEDIROM Healthcare Technologies Inc. Announces Preliminary, Unaudited Financial Results for Full Year 2024 Under Japanese GAAP

18/02/2025 - 15:00

Sustained Revenue Growth / Operating Profitability NEW YORK, Feb. 18, 2025 (GLOBE NEWSWIRE) -- MEDIROM Healthcare Technologies Inc. (Nasdaq CM: MRM), a holistic healthcare company based in Japan (the “Company”), today [...]

DoseSpot Ends Sticker Shock at the Pharmacy with Launch of New ePrescribing Solution that Gives Patients Best Pricing and Pharmacy Choice

18/02/2025 - 15:00

With New Features, DoseSpot is the First Solution to Combine an All-in-One ePrescribing Solution with Pharmacy Selection and Cost Saving Options BOSTON, Feb. 18, 2025 (GLOBE NEWSWIRE) -- DoseSpot , which delivers best- [...]

VisionHealth announces management transition as company prepares for U.S. launch of Kata® app

18/02/2025 - 15:00

Peter Shadday becomes CEO as company is moving into a commercial-stage company, increasingly focused on U.S. market opportunities Dr. Sabine Häussermann transitions to newly created role of Chief Scientific Officer to [...]

Longeveron® Announces World Health Organization Approval of “laromestrocel” as International Non-proprietary Name for Stem Cell Therapy Lomecel-B™

18/02/2025 - 15:25

Cellular therapy Lomecel-B™ has been granted an International Non-proprietary Name (INN) of “laromestrocel” on the INN List issued by the World Health Organization (WHO) Lomecel-B™ is a proprietary, scalable, allogeneic [...]

LogicMark, Inc. Announces Pricing of $14.4 Million Public Offering and Plan to Hold Special Stockholder Meeting on March 24, 2025

18/02/2025 - 15:29

LOUISVILLE, Ky., Feb. 18, 2025 (GLOBE NEWSWIRE) -- LogicMark, Inc. (NASDAQ: LGMK) (the “Company”), a provider of personal emergency response systems, health communications devices, and technology for the growing care [...]

UPDATE - Cabaletta Bio Announces Updated Clinical Data Demonstrating Deepening Clinical Responses across Multiple Indications with Rese-cel at February Scientific Meetings

18/02/2025 - 16:21

– Clinical efficacy continued to deepen over time with three SLE patients in DORIS remission, the first LN patient achieving complete renal response, and the first dermatomyositis patient maintaining a major TIS [...]

Capital Markets Day - Save the Date

18/02/2025 - 16:45

Louvain-la-Neuve, Belgique, le 18 février 2025 – IBA (Ion Beam Applications S.A., EURONEXT), leader mondial de la technologie des accélérateurs de particules, organise un Capital Markets Day (CMD), session d’information [...]

Notice of Capital Markets Day - Save the Date

18/02/2025 - 16:45

Louvain-la-Neuve, Belgium, 18 February, 2025 – IBA (Ion Beam Applications S.A., EURONEXT), the world leader in particle accelerator technology, will host a Capital Markets Day (CMD) for investors and analysts on Monday [...]

Common Myths About Non-Surgical Hair Replacement Systems Debunked by Folicure Dallas Hair Experts

18/02/2025 - 18:59

Discover the truth about non-surgical hair replacement: lightweight, natural, cost-effective, and low-maintenance solutions designed for confidence. Explore custom options with Folicure. Dallas, TX, Feb. 18, 2025 (GLOBE [...]

Highsman Releases HIT STICKS in MA, Creating an Entirely New Single-Use Cannabis Product Category

18/02/2025 - 19:09

Legendary NFL running back Ricky Williams’ newest cannabis product delivers potency, convenience and affordability in every innovative puff BOSTON, Feb. 18, 2025 (GLOBE NEWSWIRE) -- Legendary NFL running back Ricky [...]

Trio of Seasoned Healthcare Leaders Joins Greenhouse Treatment Center’s Executive Team

18/02/2025 - 22:00

GRAND PRAIRIE, Texas, Feb. 18, 2025 (GLOBE NEWSWIRE) -- Greenhouse Treatment Center has announced the appointment of three experienced healthcare professionals to its executive team. The Texas-based addiction treatment [...]

Chimerix Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

18/02/2025 - 22:01

DURHAM, N.C., Feb. 18, 2025 (GLOBE NEWSWIRE) -- Chimerix (NASDAQ:CMRX), today announced that on February 12, 2025, the Compensation Committee of Chimerix’s Board of Directors granted inducement awards to three new [...]

HealthEquity Reports Year-End Sales Metrics

18/02/2025 - 22:01

Affirms Business Outlook, Announces Upcoming Events and Presentations DRAPER, Utah, Feb. 18, 2025 (GLOBE NEWSWIRE) -- HealthEquity, Inc. (NASDAQ: HQY) ("HealthEquity" or the "Company"), the nation's largest health [...]

Iovance Biotherapeutics to Report Fourth Quarter and Full Year 2024 Financial Results and Corporate Updates on February 27, 2025

18/02/2025 - 22:01

SAN CARLOS, Calif., Feb. 18, 2025 (GLOBE NEWSWIRE) -- Iovance Biotherapeutics, Inc. (NASDAQ: IOVA), a biotechnology company focused on innovating, developing, and delivering novel polyclonal tumor infiltrating [...]

InflaRx Announces Closing of $30 Million Public Offering of Ordinary Shares and Pre-Funded Warrants

18/02/2025 - 22:01

JENA, Germany, Feb. 18, 2025 (GLOBE NEWSWIRE) -- InflaRx N.V. (Nasdaq: IFRX) (the “Company”), a biopharmaceutical company pioneering anti-inflammatory therapeutics targeting the complement system, announced today that [...]

Lyell Immunopharma Announces Participation in Upcoming Investor Conferences

18/02/2025 - 22:05

SOUTH SAN FRANCISCO, Calif., Feb. 18, 2025 (GLOBE NEWSWIRE) -- Lyell Immunopharma, Inc. (Nasdaq: LYEL), a clinical-stage company advancing a pipeline of next-generation CAR T-cell therapies for patients with cancer, [...]

NeuroPace Announces Completion of Public Offering of Common Stock and Exercise in Full of Underwriters’ Option to Purchase Additional Shares

18/02/2025 - 22:05

MOUNTAIN VIEW, Calif., Feb. 18, 2025 (GLOBE NEWSWIRE) -- NeuroPace, Inc. (Nasdaq: NPCE) today announced the completion of its previously announced underwritten public offering of 7,475,000 shares of its common stock at [...]

Fulcrum Therapeutics to Host Fourth Quarter and Full Year 2024 Financial Results Conference Call and Webcast on Tuesday, February 25, 2025, at 8:00 a.m. ET

18/02/2025 - 22:05

CAMBRIDGE, Mass., Feb. 18, 2025 (GLOBE NEWSWIRE) -- Fulcrum Therapeutics, Inc. ® (the “Company”) (Nasdaq: FULC), a clinical-stage biopharmaceutical company focused on developing small molecules to improve the lives of [...]

ANI Pharmaceuticals to Discuss Fourth Quarter and Full Year 2024 Financial Results on February 28, 2025, at 8:00 a.m. ET

18/02/2025 - 22:05

PRINCETON, N.J., Feb. 18, 2025 (GLOBE NEWSWIRE) -- ANI Pharmaceuticals, Inc. (“ANI” or the “Company”) (NASDAQ: ANIP) today announced that the Company will release its fourth quarter and full year 2024 financial results [...]